TRI102

· Tris Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TRI102, covering 2020-08-26 to 2020-08-26. Get the full timeline:

Most recent: Clinical Trial Update: TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 3]